In this lecture, Dr. Waleed Hashim will explain the importance of early and timely glycemic control for patients with T2D while highlighting on how biosimilars are developed and how they work for the patient characteristic that will benefit from adding rapid acting insulin to their regimen.
1. Understanding the importance of early and timely glycemic control for patients with diabetes.
2. Understanding how biosimilars are developed and how they work.
3. Identify patient characteristics most appropriate to add rapid acting insulin to their regimen.
Chairman: Consultant Endocrinologist, Head of Endocrine
Department, King Fahd Armed Forces Hospital
Associate executive director of centers of excellence in King Saud Medical City
Director of General Hospital in King Saud Medical City
Endocrine and diabetes clinical service line leader in Riyadh health cluster one
Head of National Trauma Registry. Saudi Health Council.